Biofarm (stock symbol BIO), one of Romania's leading drug manufacturers, recorded a net profit of 69.9 million lei in the first nine months of the year, up 6% compared to the same period last year. Turnover increased by 10% to 229 million lei, compared to 209 million lei in 2022. EBITDA reached 81.6 million lei.
"The results achieved in the first nine months of 2023 confirm our long-term development strategy. Even though the CHC market as a whole is experiencing a decrease in consumption, Biofarm manages to record growth in consumption and thus we are strengthening our position in CHC by protecting the top brands in our portfolio and by maintaining investments at a competitive level in CHC categories with high business potential. We will continue to focus on developing new solutions for patients' health, to meet their needs and to honour the company's mission of doing good for those around us through continuous improvement," said Cătălin Vicol, Biofarm CEO.
In the first nine months of 2023, Biofarm ranked 2nd in the Consumer Healthcare (CHC) segment in terms of units sold. In value terms, the company strengthened its sales to end consumers, recording an increase of more than 15% compared to the first nine months of 2022, based on the purchase price in pharmacies.
The therapeutic areas with the highest absolute growth in value in the first nine months of the year in which Biofarm is active were cold & flu, pain, magnesium-based supplements, digestion, and nasal decongestants. Biofarm brands associated with these therapeutic areas have seen increases in value market share.
The continuous development of new products, constantly adapted to the needs of consumers in continuous diversification, is one of Biofarm's pillars of growth. The company is also the volume market leader in the reference categories of 8 of its brands: Bixtonim, Colebil, Triferment, Sennalax, Extravalerianic, Carmol solution, Carbocit and Nervocalmin. This balanced mix of long-lasting brands and innovation is a strong differentiator for Biofarm's portfolio, positioning the company among the most relevant players in the CHC category.
Biofarm has invested more than 44 million euros so far in one of the most modern drug factories in Romania, which covers an impressive area of more than 10,000 square meters and has four production streams, specializing in tablets, film-coated tablets, dragees, soft capsules, solutions and syrups. This state-of-the-art plant is a key element in achieving the company's strategic objectives, which include portfolio development through line extensions, new product launches and expansion into foreign markets.
The information provided by KomuniK
The share of companies predicting a reduction in the number of employees in the upcoming year has increased to 11% in January 2025 from 2% same time last year, according to the HR Barometer survey conducted by PwC Romania. Fiscal measures taken by the government to reduce the budget deficit, such as the elimination of […]
The Veranda Mall shopping center, located near Bucharest’s busy Obor market, is up for sale and has reportedly caught the interest of real estate investors AFI Europe and M Core, Profit.ro reported. The mall is currently owned by the Pogonaru...
Romanian prime minister Marcel Ciolacu announced that a team of lawyers contracted by the government managed to block the sale of the painting Saint Sebastian by the renowned artist El Greco, which is part of Romania’s heritage. Ciolacu added that earlier this month, the government mandated lawyers to pursue the recovery through legal proceedings at […]
Romania’s eMAG and HeyBlu, a financial services company owned by the eMAG group, have announced the acquisition of Orange Money by taking over 100% of its shares. The transaction is part of eMAG’s strategy to expand and diversify its financial services, the company said. “The acquisition of Orange Money is part of eMAG’s strategy to […]
The Romanian Olympic and Sports Committee (COSR) announced the team for the European Youth Olympic Winter Festival (EYOF) Bakuriani 2025, which will take place in Georgia from February 9 to 16. Twenty athletes will compete in four disciplines, namely biathlon, alpine skiing, cross-country skiing, and snowboarding. The biathlon team comprises eight athletes, evenly split between […]
Only 28% of teenagers in Romania aged 11-15 engage in the minimum required level of physical activity and sports to maintain good health, according to a study conducted by the World Health Organization cited on High5 Podcast. Additionally, only 23% of them perform sufficient moderate and intense physical activities for their stage of development, which […]
